Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer

BACKGROUND: A subset of men with metastatic prostate cancer (mPC) responds to immune checkpoint inhibitors, and there is an unmet need to predict those most likely to benefit. We characterized circulating tumor cells (CTCs) for expression of immune checkpoint ligands in men with mPC as a non-invasiv...

Full description

Saved in:
Bibliographic Details
Published in:Biomark Res
Main Authors: Zhang, Tian, Agarwal, Anika, Almquist, R. Garland, Runyambo, Daniella, Park, Sally, Bronson, Elizabeth, Boominathan, Rengasamy, Rao, Chandra, Anand, Monika, Oyekunle, Taofik, Healy, Patrick, McNamara, Megan A., Ware, Kathryn, Somarelli, Jason A., George, Daniel J., Armstrong, Andrew J.
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Rapid Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7890610/
https://ncbi.nlm.nih.gov/pubmed/33602330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00267-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items